Percutaneous closure of perimembranous and muscular ventricular septal defects in the same session in a pediatric patient
Ventriküler septal defektlerin sol kalp yetersizliği, pulmoner vasküler hastalık, Eisenmengersendromu ve enfektif endokardit gibi muhtemel komplikasyonları sebebiyle kapatılmalarıönerilmiştir. Bu defektler konvansiyonel olarak cerrahi yolla kapatılmaktadır. Son yıllardaperkütan yolla kapatma giderek yaygınlaşmaktadır. İlk olarak perkütan kapatma müskülerdefektler için bildirilmişken günümüzde perimembranöz defektlerde başarılı bir şekildekapatılabilmektedir. Bu yazıda transtorasik ekokardiyografide tek perimembranöz ventrikülerseptal defekt tespit edilen, perkütan kapatma işlemi sırasında müsküler septumda ikinci bir defektsaptanması ile aynı seansta perkütan yolla her iki defektin kapatıldığı bir çocuk olgu sunulmuştur.
Bir çocuk hastada p erimembranöz ve musküler ventriküler sep tal def ektlerin aynı seansta p erkütan yolla kap atılması
Ventricular septal defect closure is proposed because of some possible complications such as leftheart failure, pulmonary vascular disease, Eisenmenger's syndrome and infective endocarditis.These defects are conventionally closed by surgery in general practice. Percutaneous closure isbecoming increasingly common in recent years. While percutaneous closure was first reported inmuscular defects, currently it is also used successfully for perimembranous defects. In this paperwe presented a pediatric case with a single perimembranous ventricular septal defect detected ontransthoracic echocardiography examination. The muscular defect was detected during theintervention and was closed percutaneously in the same session with the perimembranous defect
___
- 1. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57.
- 2. Serraf A, Lacour-Gayet F, Bruniaux J, Ouaknine R, Losay J, Petit J, Binet JP, Planché C. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992; 103: 437-42.
- 3. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004; 43: 1257-63.
- 4. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer Muscular VSD Occluder: Initial results and technical considerations. Cathet Cardiovasc Interv 2000; 49: 167-72.
- 5. Thanopoulos BD, Tsaousis GS, Karanasios E, Eleftherakis NG, Paphitis C. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart 2003; 89: 918-22.
- 6. Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, Balzer D, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol 2006; 47: 319-25.
- 7. Bentham JR, Gujral A, Adwani S, Archer N, Wilson N. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young 2011; 21: 271-80.
- 8. Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM. Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 2002; 55: 355-61.